As long as they keep delivering like this on the actual science, they will win in the end. Interim SP means nothing really. This should help with the Torreya process I would have thought! Just need a ROW partner willing to fund P2 & P3 for NNZ-2591. I can't see how Acadia wouldn't want to be all over this. Fits their growth strategy perfectly. With the money they have backing them, just buy NEU outright!
Ann: Compelling results for 2591 dose ranging study in PMS model, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |